Corcept Therapeutics | CORT - Zinsaufwendungen Für Schuld

Aktienkurs
46.06
Täglich Wechseln
0.98 2.17%
Monatlich
13.81%
Jährlich
-35.77%
Q2 Prognose
45.07




Zinsaufwendungen Für Schuld Veränderung Datum
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Alaunos Therapeutics USD 1.07M 215K 2023-06
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Ardelyx USD 5.76M 37K 2025-12
Assertio Holdings USD 758K 1000 2024-06
Aurora Cannabis CAD 2.11M 116K 2025-12
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Canopy Growth CAD 7.34M 1.46M 2025-12
Corcept Therapeutics USD 823.61M 21.88M 2025-09
Eli Lilly USD 114.7M 134.3M 2025-09
Esperion Therapeutics USD 22.64M 585K 2025-12
J&J USD 43M 25M 2026-03
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Merck USD 412M 85M 2025-12
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Novartis USD 304M 23M 2025-12
Novartis USD 281M 8M 2025-09
Omeros USD 4.05M 5.16M 2024-09
Pacira USD 3.89M 387K 2025-12
Pfizer USD 711M 59M 2025-12
Supernus Pharmaceuticals USD 910K 278K 2023-06
TG Therapeutics USD 6.53M 187K 2025-12